"Chemokine CCL22" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC-type chemokine with specificity for CCR4 RECEPTORS. It has activity towards TH2 CELLS and TC2 CELLS.
| Descriptor ID |
D054422
|
| MeSH Number(s) |
D12.644.276.374.200.110.900 D12.776.467.374.200.110.900 D23.125.300.110.900 D23.469.200.110.900 D23.529.374.200.110.900
|
| Concept/Terms |
Chemokine CCL22- Chemokine CCL22
- CCL22, Chemokine
- CCL22 Chemokine
- Chemokine, CCL22
- Stimulated T Cell Chemotactic Protein 1
- SCYA22 Chemokine
- Chemokine, SCYA22
- Small Inducible Cytokine A22
- CC Chemokine STCP-1
- CC Chemokine STCP 1
- Chemokine STCP-1, CC
- STCP-1, CC Chemokine
- Macrophage-Derived Chemokine
- Chemokine, Macrophage-Derived
- Macrophage Derived Chemokine
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL22".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL22".
This graph shows the total number of publications written about "Chemokine CCL22" by people in this website by year, and whether "Chemokine CCL22" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL22" by people in Profiles.
-
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance. Clin Cancer Res. 2024 Oct 01; 30(19):4450-4463.
-
Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis. Obstet Gynecol. 2017 03; 129(3):500-506.
-
Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studies. PLoS One. 2011; 6(11):e26987.
-
Chronic treatment with clenbuterol modulates endothelial progenitor cells and circulating factors in a murine model of cardiomyopathy. J Cardiovasc Transl Res. 2009 Jun; 2(2):182-90.